Morningstar Investor users sign in here.

Company Profile

  • Business description

    Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

  • Contact

    2929 Arch Street
    Suite 600
    Philadelphia PA 19104
    USA

    T: +1 267 759-3100

    E: investors@cabalettabio.com

    https://www.cabalettabio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    138

Stocks News & Analysis

stocks

This undervalued ASX share just had a moat downgrade

Morningstar’s Brian Han downgrades the company’s moat rating and cuts fair value however shares remain at an attractive discount. 
stocks

This ASX share has been awarded a moat by our analysts

Along with the narrow moat rating we raised our fair value by 12%.
video

Now the dust has settled, a mini earnings wrap

Three of our equity analysts reflect on the best results, worst disappointments and biggest market overreactions from their sectors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,361.20 20.10 0.24%
CAC 40 7,512.09 62.65 0.84%
DAX 40 18,776.47 143.36 0.77%
Dow JONES (US) 41,622.08 228.30 0.55%
FTSE 100 8,342.93 64.49 0.78%
HKSE 17,660.02 237.90 1.37%
NASDAQ 17,592.13 91.85 -0.52%
Nikkei 225 36,203.22 378.54 -1.03%
NZX 50 Index 12,671.95 32.44 -0.26%
S&P 500 5,633.09 7.07 0.13%
S&P/ASX 200 8,140.90 19.30 0.24%
SSE Composite Index 2,704.09 13.03 -0.48%

Market Movers

Name
Last price
Change
% Change
Telstra Group Ltd TLS 4.02 0.01 0.25%
Resolute Mining Ltd RSG 0.72 0.01 -0.69%
Imugene Ltd IMU 0.05 0.00 -4.00%
Pilbara Minerals Ltd PLS 2.85 0.03 -1.04%
Red 5 Ltd RED 0.33 0.01 1.54%
Sayona Mining Ltd SYA 0.02 0.00 0.00%
Westgold Resources Ltd WGX 2.67 0.09 -3.26%
South32 Ltd S32 3.23 0.06 1.89%
Appen Ltd APX 1.61 0.11 6.98%
Core Lithium Ltd CXO 0.10 0.00 -3.06%